Abbott hepatitis C genotyping test approved by FDA

theflyonthewall.com

The FDA announced the approval of a test that identifies the genotype of hepatitis C virus that apatientis carrying. The Abbott RealTime HCV Genotype II, which can differentiate genotypes 1, 1a, 1b, 2, 3, 4, and 5, using a sample of an infected patient’s blood plasma or serum, will aid health care professionals in determining the appropriate approach to treatment, the FDA added.

View Comments (0)